心血管病防治知识（下半月）
心血管病防治知識（下半月）
심혈관병방치지식（하반월）
XINXUEGUANBING FANGZHI ZHISHI
2014年
11期
43-45
,共3页
单硝酸异山梨酯缓释胶囊%治疗%心绞痛%疗效
單硝痠異山梨酯緩釋膠囊%治療%心絞痛%療效
단초산이산리지완석효낭%치료%심교통%료효
Isosorbide mononitrate sustained-release capsule%Treatment%Angina pectoris%Efficacy
目的：探讨单硝酸异山梨酯缓释胶囊治疗心绞痛的疗效。方法选取2012年10月至2013年6月我院收治的100例心绞痛患者，将其随机分成两组，每组50例，观察组采用单硝酸异山梨酯缓释胶囊配合心绞痛常规治疗，对照组采用心绞痛常规治疗，观察两组的治疗效果。结果经治疗，观察组的心电图改善情况明显优于对照组（94.0％ vs 70.0％），临床疗效也明显高于对照组（96.0％ vs 78.0％），P<0.05，具有统计学意义。结论单硝酸异山梨酯缓释胶囊治疗心绞痛的疗效显著，相对安全，有助于缓解心绞痛患者的症状，值得临床推广应用。
目的：探討單硝痠異山梨酯緩釋膠囊治療心絞痛的療效。方法選取2012年10月至2013年6月我院收治的100例心絞痛患者，將其隨機分成兩組，每組50例，觀察組採用單硝痠異山梨酯緩釋膠囊配閤心絞痛常規治療，對照組採用心絞痛常規治療，觀察兩組的治療效果。結果經治療，觀察組的心電圖改善情況明顯優于對照組（94.0％ vs 70.0％），臨床療效也明顯高于對照組（96.0％ vs 78.0％），P<0.05，具有統計學意義。結論單硝痠異山梨酯緩釋膠囊治療心絞痛的療效顯著，相對安全，有助于緩解心絞痛患者的癥狀，值得臨床推廣應用。
목적：탐토단초산이산리지완석효낭치료심교통적료효。방법선취2012년10월지2013년6월아원수치적100례심교통환자，장기수궤분성량조，매조50례，관찰조채용단초산이산리지완석효낭배합심교통상규치료，대조조채용심교통상규치료，관찰량조적치료효과。결과경치료，관찰조적심전도개선정황명현우우대조조（94.0％ vs 70.0％），림상료효야명현고우대조조（96.0％ vs 78.0％），P<0.05，구유통계학의의。결론단초산이산리지완석효낭치료심교통적료효현저，상대안전，유조우완해심교통환자적증상，치득림상추엄응용。
Objective To investigate the efficacy of isosorbide mononitrate sustained-release capsules in the treatment of angina pectoris. Methods A total of 100 patients with angina pectoris admitted to our hospital between October 2012 and June 2013 were randomly divided into observation group and control group, with 50 cases in each group. Patients in the observation group were treated with isosorbide mononitrate sustained-release capsules combined with conventional treatment for angina pectoris, while those in the control group just received conventional treatment for angina pectoris. The treatment outcomes of the two groups were compared. Results After treatment, the observation group had a significantly more electrocardiographic improvement than the control group (94.0% vs. 70.0%, P<0.05). The treatment outcome was significantly better in the observation group than in the control group (96.0% vs. 78.0%, P<0.05). Conclusion Isosorbide mononitrate sustained -release capsules have excellent efficacy in the treatment of angina pectoris. They are relatively safe for patients and helpful for relieving symptoms of angina pectoris. Due to these merits, this therapy holds promise for clinical application.
